## Core Concept
Mass chemoprophylaxis refers to the administration of chemoprophylactic agents to a large population, typically in an endemic area, to prevent the spread of a disease. This strategy is often used for diseases where the risk of transmission is high and the disease can have severe consequences. The goal is to reduce the reservoir of infection and prevent outbreaks.

## Why the Correct Answer is Right
The correct answer, D. Malaria, is the exception because while chemoprophylaxis is indeed used for malaria, mass chemoprophylaxis is not typically recommended for entire populations in endemic areas due to concerns about drug resistance, side effects, and the potential for disrupting the malaria control strategy. Instead, targeted chemoprophylaxis for high-risk groups, such as pregnant women or children, or intermittent preventive treatment (IPT) is often recommended.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is not specified, but if we consider common diseases for which mass chemoprophylaxis might be recommended, such as lymphatic filariasis or yaws, the strategy can be effective in reducing transmission.
- **Option B:** Similarly, this option is unspecified, but diseases like trachoma or certain bacterial infections might benefit from mass chemoprophylaxis in endemic areas.
- **Option C:** This option is also unspecified, but if it refers to a disease like onchocerciasis (river blindness), mass treatment with ivermectin is indeed a recommended strategy for control.

## Clinical Pearl / High-Yield Fact
A key point to remember is that mass chemoprophylaxis is usually considered for diseases with high transmission rates and significant public health impact, but its use must be carefully weighed against the potential for drug resistance and side effects. For malaria, for instance, the strategy has evolved towards more targeted approaches.

## Correct Answer: D. Malaria.